Synapsoft logo
AI Insights from Disclosures
Searching...
Genome&Company 314130
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Genome&Company has a vision of growing into a Fully Integrated Pharmaceutical Company (FIPCO) through the active expansion of its pharma-bio value chain and business model, based on innovative new drug R&D. In the pharma-bio business, which requires long-term, high costs, the company is building a balanced business portfolio for more stable and systematic growth.
Representative Director 홍유석, 배지수, 박한수 (각자 대표이사)
Founded September 24, 2015
Corporation Type KOSDAQ
Industry Classification Manufacture of medicinal chemicals
Corporate number 13411-0422240
Business number 627-87-00257
Phone Number 031-628-0150
Fax Number 070-8673-2440
Website genomecom.co.kr
Company Address 50 Changnyong-daero 256beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant